CHELSEA PENDLETON: Open Payments
NPI 1427663863 · OSAGE BEACH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,631 in 87 payments from 14 companies in 2025. Trend: 2023 $343 · 2024 $1,365 · 2025 $1,631
Food & beverage: $1,628Education: $3
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $445 |
| Regeneron Healthcare Solutions, Inc. | 12 | $205 |
| GENZYME CORPORATION | 11 | $184 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $148 |
| Verona Pharma, Inc. | 9 | $140 |
| GlaxoSmithKline, LLC. | 9 | $137 |
| Grifols USA, LLC | 5 | $85 |
| Tarsus Pharmaceuticals, Inc. | 1 | $79 |
| Electromed, Inc. | 4 | $63 |
| Viatris Specialty LLC | 3 | $56 |
Products named: DUPIXENT, FASENRA, AIRSUPRA, Ohtuvayre, NUCALA, Prolastin-C Liquid, XDEMVY, OFEV.
Industry payments across MO — which companies pay providers there.
